QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TMDX

QT71TransMedics Group, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
78.79
+5.57+7.61%
OverviewShort InterestFilings
TMDXQT71TransMedics Group, Inc.·NASDAQ
OverviewShort InterestFilings
78.79+7.61%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E14.64EPS (ttm)4.37
Insider Own4.85%
Shs Outstand34.56M
Perf Week7.07%
Market Cap2.53BForward P/E22.14EPS next Y3.56Insider Trans0.10%Shs Float-Perf Month19.14%
Enterprise Value2.93BPEG0.06EPS next Q0.53Inst Own-Short Float-Perf Quarter-30.72%
Income172.84MP/S3.98EPS this Y-53.66%Inst Trans-Short Ratio-Perf Half Y-36.99%
Sales635.89MP/B5.10EPS next Y75.72%ROA11.98%Short Interest-Perf YTD-35.23%
Book/sh14.29P/C11.43EPS next 5Y51.88%ROE41.92%52W High155.99 -49.49%Perf Year-42.15%
Cash/sh13.37P/FCF16.72EPS past 3/5Y-ROIC6.94%52W Low60.11 31.08%Perf 3Y-
Dividend Est.-EV/EBITDA20.98Sales past 3/5Y86.68% 87.65%Gross Margin59.09%Volatility3.58% 3.78%Perf 5Y-
Dividend TTM-EV/Sales4.61EPS Y/Y TTM142.57%Oper. Margin14.85%ATR (14)4.60Perf 10Y-
Dividend Ex-Date-Quick Ratio6.19Sales Y/Y TTM43.89%Profit Margin27.04%RSI (14)56.16Recom2.20
Dividend Gr. 3/5Y-Current Ratio6.74EPS Q/Q-57.14%SMA2010.20%Beta1.30Target Price121.20
Payout0.00%Debt/Eq1.75Sales Q/Q20.83%SMA50-6.62%Rel Volume1.30Prev Close73.22
Employees728LT Debt/Eq0.96EarningsJul 30SMA200-31.52%Avg Volume1.38MPrice78.79
IPO DateMay 02, 2019Option/ShortYes / YesEPS/Sales Surpr.-51.61% 0.00%Net Debt/EBITDA2.87Volume1,786,886Change7.61%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-18-26ReiteratedStifel Nicolaus$75 → $80
May-26-26ReiteratedStifel Nicolaus$85 → $75
May-06-26ReiteratedStifel Nicolaus$130 → $85
May-06-26ReiteratedRobert W. Baird$157 → $140
May-06-26ReiteratedPiper SandlerOverweight$140 → $120
May-06-26ReiteratedCanaccord GenuityBuy$148 → $124
May-06-26ReiteratedNeedhamBuy$166 → $142
Mar-09-26ReiteratedStifel Nicolaus$115 → $130
Dec-17-25ReiteratedCanaccord GenuityBuy$147 → $148
Dec-08-25ReiteratedNeedhamBuy$148 → $166
Latest News
Jun-18-26
Jun-18-2608:40AM
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue636605442
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A260243179
Gross Profit376363262
Selling, General and Administrative Excl. Other198185169
Research and Development776956
Other Operating Expense600
Operating Income9410937
Interest Expense161414
Unusual Expense
———
Non-Operating Income (Expense)-12-13-13
Net Income Before Taxes8910836
Income Taxes-83-830
Consolidated Net Income17119035
Net Income From Continuing Operations17119035
Net Income17119035
EPS (Recurring)5.035.601.07
EPS (Basic, Before Extraordinaries)5.035.601.07
EPS (Diluted)4.374.871.01
EBITDA13914870
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio18.0324.98—
Price To Sales Ratio4.216.84—
Gross Margin59.1260.0059.28
Operating Margin14.7818.028.37
Net Margin26.8931.407.92
Shares Outstanding343433
Market Capitalization2,6794,136—
Operating Lease Expense
———
Insider Trading Volume
$85.44$72.81$60.17$47.54$34.91● Close Price0.00M0.54M1.08M1.62M2.16MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Gunderson Thomas J.DirectorJun 15 '26Sale75.069,624722,37716,642Jun 17 12:00 AM
Gunderson Thomas J.DirectorJun 15 '26Option Exercise2.2138,57085,24026,266Jun 17 12:00 AM
Lovell StephanieDirectorMar 04 '26Sale149.621,193178,4972,866Mar 06 12:00 AM
Weill DavidDirectorMar 04 '26Option Exercise14.207,142101,41615,705Mar 06 12:00 AM
Weill DavidDirectorMar 04 '26Sale146.823,571524,29412,134Mar 06 12:00 AM
Hernandez GerardoChief Financial OfficerMar 04 '26Option Exercise71.1714,4721,030,00220,601Mar 04 12:00 AM
Hernandez GerardoChief Financial OfficerMar 04 '26Sale147.215,912870,30614,689Mar 04 12:00 AM
Hernandez GerardoChief Financial OfficerMar 02 '26Sale139.1237552,17014,689Mar 04 12:00 AM
Ranganath Anil P.See remarksMar 02 '26Sale139.12864120,20013,091Mar 04 12:00 AM
Corcoran NicholasSee remarksMar 02 '26Sale139.122,966412,63029,831Mar 04 12:00 AM
Hernandez GerardoChief Financial OfficerDec 04 '25Sale139.62920128,45015,064Dec 05 12:00 AM
Weill DavidDirectorDec 03 '25Option Exercise14.2010,000142,00017,134Dec 05 12:00 AM
Weill DavidDirectorDec 03 '25Sale138.645,000693,20012,134Dec 05 12:00 AM
Ranganath Anil P.See remarksNov 25 '25Option Exercise93.886,000563,28016,955Nov 26 12:00 AM
Ranganath Anil P.See remarksNov 25 '25Sale145.223,000435,66013,955Nov 26 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR